BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8133717)

  • 21. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
    Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
    Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Przybylski DJ; Reeves DJ
    Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
    Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
    Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
    Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
    Hong SN; Kim BJ; Lee SY; Lee CY; Ryu MK; Choi MS; Lee JH; Rhee PL; Koh KC; Kim JJ; Paik SW; Rhee JC; Choi KW
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):288-96. PubMed ID: 12499786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
    Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
    Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High risk febrile neutropenia in acute leukemia. The experience of a public hospital. National Program of Antineoplastic Drugs in Adult, Hospital del Salvador, 1991-2001].
    Puga B; Puga I; Cabrera ME; Undurraga MS; Guerra C; Urrejola G; Toro P
    Rev Med Chil; 2003 Sep; 131(9):1023-30. PubMed ID: 14635589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
    Goetz M; Schiel X; Heussel H; Steinmetz T; Hiddemann W; Weiss M
    Eur J Med Res; 2002 Nov; 7(11):487-90. PubMed ID: 12568977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of Tarivid and Biseptol in the prevention of bacterial infections in patients with acute leukemia].
    Mociková K; Svác J; Faber E; Wildová B; Baníková I
    Vnitr Lek; 1992 Feb; 38(2):166-72. PubMed ID: 1595205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
    Moriuchi Y; Kamihira S; Yamamura M; Mori H; Miyazaki Y; Tokunaga S; Nonaka H; Amagasaki T; Yamada Y; Yoshida Y
    Rinsho Ketsueki; 1990 Oct; 31(10):1664-9. PubMed ID: 2123946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections in acute myeloid leukemia. Study of 184 febrile episodes.
    Kumar L; Kochupillai V; Bhujwala RA
    J Assoc Physicians India; 1992 Jan; 40(1):18-20. PubMed ID: 1634456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M; Paesmans M; Calandra T; Viscoli C;
    Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
    Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
    Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
    Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
    Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
    Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
    Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.